Ann: Placement and Appendix 3B , page-9

I wondered when LK would re-enter the executive. He had to withdraw due to COI in his personal Solagran litigation - can only guess that's over now, and outcome to remain confidential. I am still trying to nut this all out, and can only consider extra funds are to facilitate a rapid entry into Asian markets with skincare lines on top of Equine development. LK has been major in BPO for a long time and must want to accelerate his return.

Key words are positive and indicate substance. ROLLOUT - COMERCIALISATION - MARKET DEVELOPMENT [ last one interesting - no APVMA approval yet - shows confidence getting approval and product potential.

"funding of rollout of REGEN? natural health products, and commercialisation of the DEMURE? and L?AZURE? natural skin care and cosmetic ranges;
? market development programs with AGRIPRO?
natural animal health products;"

last bit is interesting more irons in the fire? - small team [even with JK on board] - they need to be confident other products will be market ready [or could there be a licence agreement to be set?]

"evaluation of potential investment opportunities following a number of recent unsolicited approaches to the Company."

maybe?